shenyanggelin pharmaceutical co., Ltd. was founded on August 9, 2004, registration, address, shenbei new district, Shenyang huishan economic development zone, Shenyang, 176th North Road, type of company is a limited liability company, production areas of small capacity injection, Lyophilized Powder for Injection, API, tablets, hard capsules, and other production; transfer of pharmaceutical research and technology, food production and sales.
company covers an area of more than 20,000 square meters, including construction area of 8,000 square meters, Office laboratory building, of which more than 3,000 square meters, the 5,000 square metres of production workshop, including injection production lines, solid dosage forms production line, production line of oral liquid and raw materials; and there are nearly 10,000 square meters space can be used as the second stage construction.
consists of eight departments of the company: production department, quality Department, Ministry of Commerce, material control Department, financial Department, Chief of personnel, equipment and medicine; total number of professional and technical personnel accounting for employee 50%, product research and development accounted for 18.7% of the total number of employees, and senior professional titles in 15.74% per cent of professional and technical personnel.
injection workshop of the company has the annual production capacity of approximately 15 million of Lyophilized Powder for Injection line and the annual production capacity is approximately 20 million water injection production lines, small capacity injection and Lyophilized Powder for Injection in July 2006, the State food and Drug Administration's GMP certification, software and hardware facilities completely suitable for large-scale production. company currently General production of injection varieties has: injection with ozagrel sodium, and injection with ring phosphorus glands Glycoside, and Clinton mold pigment phosphate ester injection, and single nitric acid different sorbic ester injection, and three phosphate cell Glycoside II sodium injection, and door winter ammonia acid Lomé Sha star injection, and gegen pigment injection, and phosphate effect effects injection, and injection with forefront to erdeng 9 a varieties 16 a specifications.
companies solid Tablet preparation production line with annual output can reach 180 million (folic acid tablet, for example), the capsules production capacity reaches 80 million capsules, solid preparation workshop in March 2009 by the GMP certification, is currently being put into mass production. the company has 136 solid preparation specifications, regular varieties are produced by folic acid tablet, Qin capsule with yellow throat, lappaconitine hydrobromide tablets, Benno zinc tablets, licorice capsules, Ursodeoxycholic acid and compound methionine and CHOLINE BITARTRATE tablets.
oral workshop of the company invested $ 10 million , at present, the plant has been through the fire and environmental protection in acceptance, completed the purchase and installation of equipment and facilities, and people have been through training for posts. oral workshop in early 2011 by drug GMP certification and put into mass production. the plant varieties to extinction of fuzheng oral liquid, put into production capacity in the year production capacity is expected to reach 25,000, second annual capacity of up to 170,000, third-year industrialization 420,000 bottles.
company has get clinical superior of drug varieties "m flexor hydrazine injection" (of drug 3.1 class) for I company innovation drug, has completed ⅱ period clinical test, currently is prepared reported production of related work; I company on the varieties has independent intellectual property, Mi Qujing injection main should for brain vascular disease, as brain deficiency blood, and dementia, and around blood flow disorder,, is treatment and secondary treatment heart brain vascular disease of preferred drug, has very widely of clinical application prospects, Elaboration of the company's core product.
varieties of traditional Chinese medicines "extinction of fuzheng oral liquid" is our own exclusive products, are declared to the State intellectual property office patent, the varieties with enhanced immune function , in order to effectively achieve the purpose of suppression and cancer treatment. at present, the company has completed construction of oral-shop, passed GMP certification and put into mass production in early 2011.
for product and sales of the different regional characteristics, company sales for different modes of operation, is the clinical distribution, taking into account allocation of business, the second is the logistics of radiation; three is the third terminal of the direct sales model.
for procurement, government procurement-oriented, such as "folic acid" full use "folic acid for all" concept, free markets in villages and towns added that focus on occupation of the city market, enhanced Terminal sales, it is necessary to explore key distribution, key customers and sales policy.
company in July 2010 ISO environmental management system and quality management system certification, and have access to provincial and municipal industry and Commerce departments to grant "complying with contract, emphasizing on credit" unit.